- Home
- IRT vs VKTX Comparison
IRT vs VKTX Comparison
Compare IRT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRT
- VKTX
- Stock Information
- Founded
- IRT 2009
- VKTX 2012
- Country
- IRT United States
- VKTX United States
- Employees
- IRT N/A
- VKTX N/A
- Industry
- IRT Real Estate Investment Trusts
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- IRT Real Estate
- VKTX Health Care
- Exchange
- IRT Nasdaq
- VKTX Nasdaq
- Market Cap
- IRT 3.8B
- VKTX 3.8B
- IPO Year
- IRT 2013
- VKTX 2015
- Fundamental
- Price
- IRT $16.26
- VKTX $36.47
- Analyst Decision
- IRT Buy
- VKTX Strong Buy
- Analyst Count
- IRT 7
- VKTX 14
- Target Price
- IRT $22.14
- VKTX $87.00
- AVG Volume (30 Days)
- IRT 3.4M
- VKTX 4.7M
- Earning Date
- IRT 10-29-2025
- VKTX 10-22-2025
- Dividend Yield
- IRT 4.19%
- VKTX N/A
- EPS Growth
- IRT N/A
- VKTX N/A
- EPS
- IRT 0.09
- VKTX N/A
- Revenue
- IRT $662,924,000.00
- VKTX N/A
- Revenue This Year
- IRT $4.19
- VKTX N/A
- Revenue Next Year
- IRT $4.72
- VKTX N/A
- P/E Ratio
- IRT $178.44
- VKTX N/A
- Revenue Growth
- IRT 3.70
- VKTX N/A
- 52 Week Low
- IRT $15.07
- VKTX $18.92
- 52 Week High
- IRT $22.26
- VKTX $70.41
- Technical
- Relative Strength Index (RSI)
- IRT 50.95
- VKTX 58.74
- Support Level
- IRT $15.07
- VKTX $33.00
- Resistance Level
- IRT $16.12
- VKTX $39.57
- Average True Range (ATR)
- IRT 0.35
- VKTX 2.31
- MACD
- IRT 0.06
- VKTX -0.01
- Stochastic Oscillator
- IRT 85.05
- VKTX 64.42
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.